shutterstock_636880342
News
UK unveils funding for AI companies to transform cancer care and spark new drug...
New AI models to diagnose and treat cancer and other incurable diseases will be made possible thanks to joint public-private investment giving flexible funding...
U.S. FDA approves SpringWorks Therapeutics’ GOMEKLI for patients with NF1-PN
The U.S. Food and Drug Administration (FDA) has approved SpringWorks Therapeutics' GOMEKLI (mirdametinib), SpringWorks’ MEK inhibitor, for the treatment of adult and pediatric patients...
U.S. FDA approves EMBLAVEO for adults with complicated intra-abdominal infections
The U.S. Food and Drug Administration (FDA) has approved AbbVie's EMBLAVEO (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination...
